Overview
InnovateHealth Biotech Solutions is a pioneering startup in the biotechnology industry focused on developing innovative therapies for chronic diseases such as diabetes and cardiovascular disorders. Since our inception in 2024, we have assembled a talented team of experts in pharmaceuticals and molecular biology, leading to successful early-stage trials of our proprietary therapeutic platform. Our technology employs advanced biomolecular techniques to enhance drug efficacy and reduce side effects, setting a new standard in patient care. To date, we have secured initial seed funding of $500,000, which has allowed us to complete preclinical studies with positive outcomes. The feedback from our trials indicates a 75% improvement in treatment effectiveness compared to existing therapies. As we prepare to transition into clinical trials in Q1 2027, we are looking for an investor who shares our vision for transforming chronic disease management and is keen to contribute to a project with promising potential. In addition to elevating treatment outcomes, our project aims to lower healthcare costs significantly, addressing a major pain point in the current healthcare system. With the support…
Use of funds
The $1.5 million investment will be allocated as follows:
- Clinical Trial Costs: $800,000 for Phase I and II trials.
- Research and Development: $400,000 to refine our therapeutic platform.
- Regulatory Compliance: $200,000 for legal and compliance costs associated with FDA approval.
- Operational Costs: $100,000 for staffing and overhead expenses during the trial phases.
- Marketing Strategy: $100,000 for building a brand presence and outreach to healthcare providers.
Open case
Open this case to get the detailed business plan and direct contact with the founder or seeker.